VEGFA and diabetic kidney disease: We show that in db/db mice the splicing and expression of VEGF-A are altered to increase the pro-angiogenic VEGF-A164 and decrease the anti-angiogenic VEGF-A165b, which is consistent with what is reported in human diabetic nephropathy [7].